Breaking news from ESMO 2025: liquid biopsy novelties in gastrointestinal cancer
{{output}}
Liquid biopsy (LB) has emerged as a minimally invasive approach to characterize tumor biology and support treatment decision-making across gastrointestinal (GI) malignancies. Advances in circulating biomarkers have expanded its potential clinical applications.... ...